E-LIB Suche - Ergebnisse für: Ray, A. K.

1

Analyses of the model parameters of kinematic-isotropic har..:

Nath, Atri ; Ray, Ayan ; Ray, K.K.
Procedia Structural Integrity. 43 (2023) - p. 246-251 , 2023

Link: https://doi.org/10.1016/..

2

Evolocumab use in Greece is associated with early and susta..:

Vlachopoulos, C. ; Massia, D. ; Kochiadakis, G....
Hellenic Journal of Cardiology. 74 (2023) - p. 74-76 , 2023

Link: https://doi.org/10.1016/..

3

Physica status solidi

Volume 75, Number 2: February 16 Physica status solidi ; Volume 75, Number 2, A

Abdel-Salam, F ; Abreu, R. A ; Akhmetov, V. D... - Reprint 2021 . , [2022]

Link: https://doi.org/10.1515/..

4

Baseline characteristics and management of high- and very h..:

Ray, K.K. ; Haq, I. ; Bilitou, A....
Atherosclerosis. 355 (2022) - p. 16 , 2022

Link: https://doi.org/10.1016/..

5

Residual risk of major adverse cardiovascular and limb even..:

Vallejo-Vaz, A.J. ; Dharmayat, K.I. ; Nzeakor, N....
Atherosclerosis. 355 (2022) - p. 31 , 2022

Link: https://doi.org/10.1016/..

6

LDL-cholesterol goal attainment through optimal implementat..:

Brandts, J. ; Bray, S. ; Villa, G....
Atherosclerosis. 355 (2022) - p. 23-24 , 2022

Link: https://doi.org/10.1016/..

7

Identification, characteristics and management of adults wi..:

Vallejo-Vaz, A.J. ; Stevens, C.A. ; Dharmayat, K.I....
Atherosclerosis. 355 (2022) - p. 15-16 , 2022

Link: https://doi.org/10.1016/..

8

Cardiovascular risk assessment by physicians and lipid-lowe..:

Ray, K.K. ; Haq, I. ; Bilitou, A....
Atherosclerosis. 355 (2022) - p. 249 , 2022

Link: https://doi.org/10.1016/..

9

Obicetrapib lowers LDL-C in patients on high intensity stat..:

Ray, K.K. ; Nicholls, S. ; Ditmarsch, M....
Atherosclerosis. 355 (2022) - p. 11-12 , 2022

Link: https://doi.org/10.1016/..

10

LDL-C goal achievement and lipid-lowering therapy in patien..:

Catapano, A L ; Manu, M C ; Burden, A.
European Heart Journal. 43 (2022) Supplement_2 - p. , 2022

Link: https://doi.org/10.1093/..

11

Evolocumab treatment is associated with early and sustained..:

Ray, K K ; Perrone-Filardi, P ; Ebenbichler, C...
European Heart Journal. 43 (2022) Supplement_2 - p. , 2022

Link: https://doi.org/10.1093/..

12

Global perspective of paediatric Familial Hypercholesterola..:

Dharmayat, K.I. ; Vallejo-Vaz, A.J. ; Stevens, C.A....
Atherosclerosis. 355 (2022) - p. 13 , 2022

Link: https://doi.org/10.1016/..

13

Final results from the pan-European observational heymans s..:

Ray, K.K. ; Bruckert, E. ; Perrone-Filardi, P....
Atherosclerosis. 355 (2022) - p. 14 , 2022

Link: https://doi.org/10.1016/..

14

Simulation of bempedoic acid in the lipid-lowering treatmen..:

Ray, K K ; Catapano, A L ; Diamand, F...
European Heart Journal. 43 (2022) Supplement_2 - p. , 2022

Link: https://doi.org/10.1093/..

15

High long-term persistence to evolocumab treatment regimens..:

Ray, K K ; Perrone-Filardi, P ; Ebenbichler, C...
European Heart Journal. 43 (2022) Supplement_2 - p. , 2022

Link: https://doi.org/10.1093/..